Cantor Fitzgerald’s Humana HUM Stock Holding History

Cantor Fitzgerald’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,000	Closed	-$53.1K	–	252
2024 Q2	$53.1K	Buy	+5,000	New	+$1.69M	0.01%	179

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Cantor Fitzgerald's HUM Position: Q1 2023 in Review

Cantor Fitzgerald sold out of Humana (HUM) in Q1 2023, closing a stake of 430 shares — an estimated $220K sold.

Cantor Fitzgerald first reported a position in HUM in Q4 2022 and held it in 1 quarter. The position peaked at $220K in Q4 2022. 1,045 funds tracked by Wall St. Rank hold HUM as of Q1 2023.

Cantor Fitzgerald reported no remaining Humana position as of Q1 2023 after selling out during the quarter.
Cantor Fitzgerald sold 430 Humana shares in Q1 2023, an estimated $220K.
Cantor Fitzgerald first reported a position in Humana in Q4 2022 and held it in 1 quarter.
Cantor Fitzgerald's Humana position peaked at $220K in Q4 2022.
1,045 funds tracked by Wall St. Rank held Humana as of Q1 2023.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.